Non-Genetic Risk Factors of Alzheimer's Disease: An Updated Umbrella Review

Overview

Journal J Prev Alzheimers Dis

Specialty Neurology

Date 2024 Jul 24

PMID 39044503

Authors

S-Y He

W-M Su

X-J Wen

S-J Lu

B Cao

B Yan

Y-P Chen

Affiliations

Soon will be listed here.

Abstract

Background: Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by intricate genetic and environmental etiology. The objective of this study was to identify robust non-genetic risk factors for AD through an updated umbrella review.

Methods: We conducted a comprehensive search of meta-analyses and systematic reviews on non-genetic risk factors associated with AD in PubMed, Cochrane, Embase, and Ovid Medline up to June 30, 2023. After collecting data, we estimated the summary effect size and their 95% confidence intervals. The degree of heterogeneity between studies was assessed using I2 statistics and a 95% prediction interval was determined. Additionally, we evaluated potential excess significant bias and small study effects within the selected candidate studies.

Results: The umbrella review encompassed a total of 53 eligible papers, which included 84 meta-analyses covering various factors such as lifestyle, diet, environmental exposures, comorbidity or infections, drugs, and biomarkers. Based on the evidence classification criteria employed in this study, two factors as convincing evidence (Class I), including rheumatoid arthritis (RA), potentially reduced the risk of AD, but diabetes significantly increased the risk of AD. Furthermore, three factors as highly suggestive evidence (Class II), namely depression, high homocysteine, and low folic acid level, potentially increased the risk of AD.

Conclusion: Our findings highlight several risk factors associated with AD that warrant consideration as potential targets for intervention. However, it is crucial to prioritize the identified modifiable risk factors, namely rheumatoid arthritis, diabetes, depression, elevated homocysteine levels, and low folic acid levels to effectively address this complex neurodegenerative disorder.

References

Tsang S, Vinters H, Cummings J, Wong P, Chen C, Lai M . Alterations in NMDA receptor subunit densities and ligand binding to glycine recognition sites are associated with chronic anxiety in Alzheimer's disease. Neurobiol Aging. 2007; 29(10):1524-32. PMC: 2667969. DOI: 10.1016/j.neurobiolaging.2007.03.014. View

Fusar-Poli P, Radua J . Ten simple rules for conducting umbrella reviews. Evid Based Ment Health. 2018; 21(3):95-100. PMC: 10270421. DOI: 10.1136/ebmental-2018-300014. View

Barnes D, Yaffe K . The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011; 10(9):819-28. PMC: 3647614. DOI: 10.1016/S1474-4422(11)70072-2. View

Ganguli M . Depression, cognitive impairment and dementia: Why should clinicians care about the web of causation?. Indian J Psychiatry. 2011; 51 Suppl 1:S29-34. PMC: 3038544. View

Kim B, Lee S, Graham P, Angelucci F, Lucia A, Pareja-Galeano H . Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis. Mol Neurobiol. 2016; 54(9):7297-7311. DOI: 10.1007/s12035-016-0192-9. View

Chinn S . A simple method for converting an odds ratio to effect size for use in meta-analysis. Stat Med. 2000; 19(22):3127-31. DOI: 10.1002/1097-0258(20001130)19:22<3127::aid-sim784>3.0.co;2-m. View

Lau J, Ioannidis J, Schmid C . Quantitative synthesis in systematic reviews. Ann Intern Med. 1998; 127(9):820-6. DOI: 10.7326/0003-4819-127-9-199711010-00008. View

Wang Z, Wei X, Yang J, Suo J, Chen J, Liu X . Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis. Neurosci Lett. 2015; 610:200-6. DOI: 10.1016/j.neulet.2015.11.014. View

Lee J, Choi G, Kang H, Baek C, Jung Y, Shin H . Relationship between Surgery under General Anesthesia and the Development of Dementia: A Systematic Review and Meta-Analysis. Biomed Res Int. 2020; 2020:3234013. PMC: 7165327. DOI: 10.1155/2020/3234013. View

10.

Liu N, Wang Y, He L, Sun J, Wang X, Li H . Inflammatory bowel disease and risk of dementia: An updated meta-analysis. Front Aging Neurosci. 2022; 14:962681. PMC: 9581261. DOI: 10.3389/fnagi.2022.962681. View

11.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

12.

Li H, Zhao S, Wang R, Gao B . The association between cognitive impairment/dementia and albuminuria: a systematic review and meta-analysis. Clin Exp Nephrol. 2021; 26(1):45-53. PMC: 8738457. DOI: 10.1007/s10157-021-02127-3. View

13.

Shen L, Ji H . Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses. J Alzheimers Dis. 2015; 46(3):777-90. DOI: 10.3233/JAD-150140. View

14.

Wang J, Tan L, Wang H, Tan C, Meng X, Wang C . Anti-inflammatory drugs and risk of Alzheimer's disease: an updated systematic review and meta-analysis. J Alzheimers Dis. 2014; 44(2):385-96. DOI: 10.3233/JAD-141506. View

15.

Koch G, Di Lorenzo F, Bonni S, Giacobbe V, Bozzali M, Caltagirone C . Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients. Neuropsychopharmacology. 2014; 39(11):2654-61. PMC: 4207345. DOI: 10.1038/npp.2014.119. View

16.

Ou Y, Zhu J, Hou X, Shen X, Xu W, Dong Q . Associations of Infectious Agents with Alzheimer's Disease: A Systematic Review and Meta-Analysis. J Alzheimers Dis. 2020; 75(1):299-309. DOI: 10.3233/JAD-191337. View

17.

Policicchio S, Ahmad A, Powell J, Proitsi P . Rheumatoid arthritis and risk for Alzheimer's disease: a systematic review and meta-analysis and a Mendelian Randomization study. Sci Rep. 2017; 7(1):12861. PMC: 5634412. DOI: 10.1038/s41598-017-13168-8. View

18.

Lautenschlager N, Cox K, Flicker L, Foster J, Bockxmeer F, Xiao J . Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA. 2008; 300(9):1027-37. DOI: 10.1001/jama.300.9.1027. View

19.

Rahmani J, Roudsari A, Bawadi H, Clark C, Ryan P, Salehisahlabadi A . Body mass index and risk of Parkinson, Alzheimer, Dementia, and Dementia mortality: a systematic review and dose-response meta-analysis of cohort studies among 5 million participants. Nutr Neurosci. 2020; 25(3):423-431. DOI: 10.1080/1028415X.2020.1758888. View

20.

Dhiman V, Trushna T, Raj D, Tiwari R . Is Air Pollution Associated with Increased Risk of Dementia? A Meta-Analysis of Epidemiological Research. Neurol India. 2022; 70(3):1004-1019. DOI: 10.4103/0028-3886.349654. View